• Home
  • Industry
  • Innovation
  • Market
  • Materials
  • Products
  • Subscribe
  • Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

Japan Chemical Daily

Japan's leading chemical industry newspaper

Log In

Lost your password?
Forgotten Password
Cancel
  • Home
  • Industry
  • Products
  • Materials
  • Innovation
  • Market
  • Sustainability
  • Regulatory
  • About Us
    • President’s Message
    • The Chemical Daily
  • Subscribe
    • Q & A
    • Subscribe Now
    • Manage my Subscription
    • Subscribe to our E-Mail Newsletter
  • 日本語
    • 化学工業日報
    • 広告掲載について

LSII to Launch Clinical Trials of Muse Cells to Treat Respiratory Failure in COVID-19 Patients

Apr. 23, 2021

Filed Under: Coronavirus, Pharma Tagged With: clinical trials, coronavirus, health care, Life Science Institute, medical, Mitsubishi Chemical Holdings, Muse cells, stem cells

Mitsubishi Chemical Holdings Corp. (TYO:4188) subsidiary Life Science Institute Inc. (LSII) plans to begin clinical trials of a Muse cell-based…...

Please subscribe to read the full story.

Subscribe Free Trial

Related Articles:

Asahi Kasei Works on New iPS Treatments for Orthopedic Sector
Asahi Kasei Works on New iPS Treatments for Orthopedic…
Kyoto University Venture Thyas Uses iPS Cells to Generate Killer T Cells for Cancer Treatment
Kyoto University Venture Thyas Uses iPS Cells to Generate…
Keio University Venture Looks to Achieve Breakthrough in Cardiovascular Regenerative Medicine
Keio University Venture Looks to Achieve Breakthrough in…
Coronavirus Report – Part 27: Pandemic Sees Clinical Trials for New Drugs Suspended, Postponed
Coronavirus Report – Part 27: Pandemic Sees Clinical Trials…
Coronavirus Report – Part 67: Pandemic Causes 75% Drop in Clinical Trials for Early April
Coronavirus Report – Part 67: Pandemic Causes 75% Drop in…
Coronavirus Report – Part 58: Clinical Trials Begin for Slew of Potential Vaccines
Coronavirus Report – Part 58: Clinical Trials Begin for Slew…
Previous Post: « Chinese Economy Continues to Rebound
Next Post: China Looks to Take the Lead in Growing EV Battery Market »

Primary Sidebar

Latest Articles

Profits of Three Major Ink Manufacturers Fall for January–March Amid Surging Raw Material Prices

May. 20, 2022

Mitsubishi Gas Chemical Moves Forward With Business Portfolio Reforms

May. 20, 2022

Toray Fine Chemicals to Produce More Raw Materials for Adhesives, Nonwovens for Masks

May. 20, 2022

Eight Chemical Industry Power Players Combine to Post Record High in Operating Income for FY2021

May. 19, 2022

Interview: Covestro Thailand Managing Director Timo Slawinski Discusses Business Environment, Plans

May. 19, 2022

Most Popular

  • Interview: Mitsubishi Chemical Holdings Corporate Executive Officer Hitoshi Sasaki Discusses MMA Business
  • Sodium Batteries Near Practical Use as Chinese Manufacturers Target Application in EVs and More
  • Mitsubishi Chemical Holdings Targets End of Fiscal 2022 for BN Sheet Commercialization
  • Nissan Chemical Looks to Boost Profitability From New Products as Part of New Six-Year Plan
  • Mitsubishi Gas Chemical Moves Forward With Business Portfolio Reforms

Tags

asahi kasei Automotive automotive materials batteries china CO2 CO2 emissions coronavirus electric vehicles environment ethylene EV health care industry trends interview investments LiB LiB materials M&A market conditions medical METI Mitsubishi Chemical Mitsubishi Chemical Holdings Mitsui Chemicals new facilities new materials petrochemical pharmaceutical polypropylene production production increase R&D recycling semiconductors Showa Denko strategy Sumitomo Chemical supply and demand Teijin thailand Toray tosoh U.S. ube industries

Footer

Log In


Lost your password?
Forgotten Password
Cancel

Links

Home
About
広告掲載について
Terms of Use
Privacy Policy
Legal Notice
Notation on the Specified Commercial Transaction Act
Contact us

© 2016–2021 The Chemical Daily Co. Ltd., Bonuterra Inc. All Rights Reserved.

japan-industry-news-network_logo

Copyright © 2022 · Chemical Daily v2 on Genesis Framework · WordPress · Log in